These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7066173)

  • 1. Early kinetics of intravenous propranolol.
    Fagan TC; Walle T; Walle UK; Conradi EC; Harmon G; Gaffney TE
    Br J Clin Pharmacol; 1982 Apr; 13(4):571-4. PubMed ID: 7066173
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous propranolol in patients with inflammation.
    Waller DG; Smith CL; Renwick AG; George CF
    Br J Clin Pharmacol; 1982 Apr; 13(4):577-8. PubMed ID: 7066175
    [No Abstract]   [Full Text] [Related]  

  • 3. The disposition of propranolol. I. Elimination during oral absorption in man.
    Shand DG; Rangno RE
    Pharmacology; 1972; 7(3):159-68. PubMed ID: 5054586
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological determinants of propranolol disposition in man.
    Kornhauser DM; Wood AJ; Vestal RE; Wilkinson GR; Branch RA; Shand DG
    Clin Pharmacol Ther; 1978 Feb; 23(2):165-74. PubMed ID: 620476
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioavailability of propranolol in the dog.
    Tse FL; Sanders TM; Reo JP
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):180-9. PubMed ID: 7224706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.
    Evans GH; Shand DG
    Clin Pharmacol Ther; 1973; 14(4):487-93. PubMed ID: 4723255
    [No Abstract]   [Full Text] [Related]  

  • 7. Arterial and venous blood sampling in pharmacokinetic studies: propranolol in rabbits and dogs.
    Lam G; Chiou WL
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):33-48. PubMed ID: 7268207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma propranolol levels in adults with observations in four children.
    Shand DG; Nuckolls EM; Oates JA
    Clin Pharmacol Ther; 1970; 11(1):112-20. PubMed ID: 5410893
    [No Abstract]   [Full Text] [Related]  

  • 9. No stereoselective first-pass hepatic extraction of propranolol.
    Jackman GP; McLean AJ; Jennings GL; Bobik A
    Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presystemic and systemic glucuronidation of propranolol.
    Walle T; Fagan TC; Conradi EC; Walle UK; Gaffney TE
    Clin Pharmacol Ther; 1979 Aug; 26(2):167-72. PubMed ID: 455886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.
    Cleaveland CR; Shand DG
    Clin Pharmacol Ther; 1972; 13(2):181-5. PubMed ID: 4401564
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacokinetics of propranolol.
    Routledge PA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):73-90. PubMed ID: 378502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct measurement of propranolol bioavailability during accumulation to steady-state.
    Wood AJ; Carr K; Vestal RE; Belcher S; Wilkinson GR; Shand DG
    Br J Clin Pharmacol; 1978 Oct; 6(4):345-50. PubMed ID: 698031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of individual differences in gastric emptying to variability in plasma propranolol concentrations.
    Castleden CM; George CF; Short MD
    Br J Clin Pharmacol; 1978 Feb; 5(2):121-2. PubMed ID: 619945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between propranolol kinetics and its electrophysiologic effects.
    Latini R; Riva E; Cremonesi A; Zacá F; Pagliarani P
    Ther Drug Monit; 1980; 2(2):143-4. PubMed ID: 7052284
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of intravenous propranolol on the electrocardiographic curve].
    Pyzik Z; Sedziwy L
    Pol Tyg Lek; 1970 Nov; 25(47):1805-8. PubMed ID: 5484519
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of propranolol on the electrocardiogram in Wolff-Parkinson-White disease].
    Szczeklik J; Pyzik Z
    Pol Tyg Lek; 1971 Mar; 26(9):302-5. PubMed ID: 5550666
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of heparin administration on the plasma protein binding and disposition of propranolol.
    Silber B; Lo M; Riegelman S
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):419-29. PubMed ID: 7384636
    [No Abstract]   [Full Text] [Related]  

  • 20. Stereoselective clearance and distribution of intravenous propranolol.
    Olanoff LS; Walle T; Walle UK; Cowart TD; Gaffney TE
    Clin Pharmacol Ther; 1984 Jun; 35(6):755-61. PubMed ID: 6734027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.